Academic Article

Academic Article RDF

5-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity
5-aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor alpha-responsive mouse genes is AICAR 5'-monophosphate-dependent and AMP-activated protein kinase-independent
5-Azido neuraminic acid thioglycoside as sialylation donor
5-HT receptor classification and nomenclature: Towards a harmonization with the human genome
5-HT receptor nomenclature: Naming names, does it matter? A tribute to Maurice Rapport
5-HT(1A) receptor activation: short-term effects on the mRNA expression of the 5-HT(1A) receptor and galanin in the raphe nuclei
5-HT(1A) receptor binding in the dorsal raphe nucleus is implicated in the anxiolytic-like effects of Cinnamomum cassia
5-ht(1a) receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups
5-HT(1A) receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission
5-HT(2C) agonists as therapeutics for the treatment of schizophrenia
5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine
5-HT(7) receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern
5-HT1A autoreceptors in the dorsal raphe nucleus convey vulnerability to compulsive cocaine seeking
5-HT2C receptor structures reveal the structural basis of GPCR polypharmacology
5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfany l-1- 4-(5-methoxy-pyrimidin-2-yl)-benzyl -1H-indol-2-yl}-2,2-dimethyl-pr opionic acid (AM679)-A potent FLAP inhibitor
5-lipoxygenase-activating protein inhibitors: development of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103)
5-N,4-O-carbonyl-7,8,9-tri-O-chloroacetyl-protected sialyl donor for the stereoselective synthesis of alpha-(2-->9)-tetrasialic acid
5S rRNA gene transcription factor IIIA alters the helical configuration of DNA
6,7-dihydroxyisoquinoline-3-carboxylic acids are potent inhibitors on the binding of insulin-like growth factor (IGF) to IGF-binding proteins: Optimization of the 1-position benzoyl side chain
6,8-di-C-glycosyl flavonoids from Dendrobium huoshanense
6,9-pyridazaprostacyclin and derivatives: the first "aromatic" prostacyclins
6,9-thiaprostacyclin. A stable and biologically potent analogue of prostacyclin (PGI2)
6-alkynyl fucose is a bioorthogonal analog for O-fucosylation of epidermal growth factor-like repeats and thrombospondin Type-1 repeats by protein O-fucosyltransferases 1 and 2
6-Deoxyerythronolide B synthase thioesterase-catalyzed macrocyclization is highly stereoselective
6-endo-hydroxy-3-endo-aminomethylbicyclo[2.2.1]heptane-2-endo-carboxylic acid lactam
6-substituted hexamethylene amiloride (HMA) derivatives as potent and selective inhibitors of the human urokinase plasminogen activator for use in cancer
68Ga-PSMA-11 PET imaging of response to androgen receptor inhibition: first human experience
7-alkylidenecephalosporin esters as inhibitors of human leukocyte elastase
7-Chlorokynurenate Ameliorates Neuronal Injury Mediated by HIV Envelope Protein gp120 in Rodent Retinal Cultures
7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1